ELIQUIS (Apixaban)

ELIQUIS (Apixaban) is an oral anticoagulant that plays a crucial role in the prevention and treatment of various blood clotting disorders. It is primarily prescribed to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation, a condition characterized by irregular heartbeats. ELIQUIS works by inhibiting Factor Xa, an essential component in the coagulation cascade, thereby preventing the formation of harmful clots.

Some key highlights of ELIQUIS include:

• Indications: ELIQUIS is indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and the prevention of DVT and PE following hip or knee replacement surgery.


• Dosage: The dosage of ELIQUIS can vary based on the condition being treated, but it is typically taken twice daily. It is essential for patients to follow their healthcare provider's instructions regarding dosage.


• Advantages: ELIQUIS has a predictable pharmacokinetic profile, which means it does not usually require routine blood monitoring, making it a convenient option for many patients.


• Side Effects: Common side effects may include bleeding complications, which can be serious. Patients should be aware of signs of bleeding and seek medical attention if they occur.


• Drug Interactions: ELIQUIS can interact with other medications, so it is important for patients to inform their healthcare providers about all medications they are taking, including over-the-counter drugs and supplements.


• Precautions: ELIQUIS should be used with caution in patients with renal impairment, liver disease, or those at increased risk of bleeding.

In conclusion, ELIQUIS is a vital medication for managing blood clot-related conditions. Its effectiveness, combined with the convenience of not requiring regular monitoring, makes it a preferred choice for many patients under the guidance of their healthcare providers.

• Apixaban


• Inactive ingredients:


• Microcrystalline cellulose


• Colloidal silicon dioxide


• Magnesium stearate


• Hydroxypropyl methylcellulose


• Triacetin


• Iron oxide red


• Iron oxide yellow

ELIQUIS (Apixaban) is an anticoagulant medication used to reduce the risk of stroke and blood clots in individuals with certain medical conditions. To use ELIQUIS safely and effectively, follow these instructions:

1. Consult your healthcare provider before starting ELIQUIS to ensure it is appropriate for your condition and to discuss any potential interactions with other medications.




2. Take ELIQUIS exactly as prescribed by your healthcare provider. The usual recommended dosage is twice daily, with or without food.




3. Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet.




4. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at once.




5. Monitor for any signs of bleeding, such as unusual bruising, blood in urine or stool, or prolonged bleeding from cuts. Report any such symptoms to your healthcare provider immediately.




6. Inform your healthcare provider about any planned surgeries or dental procedures, as ELIQUIS may need to be temporarily discontinued.




7. Do not stop taking ELIQUIS without consulting your healthcare provider, as this may increase the risk of blood clots.




8. Store ELIQUIS at room temperature, away from moisture and heat. Keep it out of reach of children.

Regular check-ups with your healthcare provider are important to monitor your condition and adjust your dosage if necessary. Always keep an updated list of all medications you are taking and share this information with your healthcare provider.